Cardiovascular Disease Attributable to High Systolic Blood Pressure in Younger Adults Requires Greater Attention: Insights from the Global Burden of Disease Study 2021
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.041964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Fanqi Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The Second Xiangya Hospital of Central South University Changsha China. Hauptthemen laut MEDLINE: Hypertension, Cardiovascular Diseases, Blood Pressure. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Cardiovascular disease (CVD) represents the most significant global burden among all diseases. High systolic blood pressure (HBP) is the most prevalent risk factor for CVD. This study aims to investigate the global burden of CVDs attributable to high systolic blood pressure (HBP‐CVD) and to assess the effectiveness of disease control across different age groups.
Methods
The burden was assessed by analyzing the numbers, age‐standardized rates of deaths, and disability‐adjusted life‐years, alongside the corresponding estimated annual percentage change, stratified by age, sex, sociodemographic index, and geographical regions.
Results
From 1990 to 2021, the age‐standardized rates of death and disability‐adjusted life‐years declined, with estimated annual percentage changes of −1.45 and −1.36, respectively. However, owing to the growth in population, the current burden of HBP‐CVD is increasing. The age‐period‐cohort model suggests that the alleviation of disease burden is more pronounced in populations ≥50 years of age, with the lowest point occurring around 70 years of age. The age‐stratified estimated annual percentage change further substantiates this issue, revealing that disease control efforts are least effective in the 15 to 49 years of age group, compared with the 50 to 69 and 70+ years of age groups. Overall, health inequities in HBP‐CVD are decreasing, yet they persist. More importantly, health inequities in the 15 to 49 years of age group have exacerbated from 1990 to 2021.
Conclusions
The burden of HBP‐CVD remains severe, and disease control was least effective in the 15 to 49 years of age group compared with the 50 to 69 and 70+ years of age groups. Urgent adjustments to health care policies are imperative.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology The Second Xiangya Hospital of Central South University Changsha China.
- Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence Southern Medical University Guangzhou China.
ORCID-Profile: Fanqi Li, Jiasong Li, Gaoming Zeng, Qiuzhen Lin, Qiming Liu
Zitieren
APA
Li, F., Li, J., Tan, S., Zeng, G., Zhu, J., Zhou, J., Zhang, Z., Lin, Q., Liu, N., & Liu, Q. (2025). Cardiovascular Disease Attributable to High Systolic Blood Pressure in Younger Adults Requires Greater Attention: Insights from the Global Burden of Disease Study 2021. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.041964
Vancouver
Li F, Li J, Tan S, Zeng G, Zhu J, Zhou J, et al. Cardiovascular Disease Attributable to High Systolic Blood Pressure in Younger Adults Requires Greater Attention: Insights from the Global Burden of Disease Study 2021. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.041964
BibTeX
@article{Li2025,
author = {Li, Fanqi and Li, Jiasong and Tan, Siyuan and Zeng, Gaoming and Zhu, Jiayi and Zhou, Jiabao and Zhang, Zixi and Lin, Qiuzhen and Liu, Na and Liu, Qiming},
title = {Cardiovascular Disease Attributable to High Systolic Blood Pressure in Younger Adults Requires Greater Attention: Insights from the Global Burden of Disease Study 2021},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.041964}
}
EUVIMED